Suppr超能文献

临床前阿尔茨海默病患者的脑白质弥散受限更明显。

Greater Diffusion Restriction in White Matter in Preclinical Alzheimer Disease.

机构信息

Department of Neurology, Medical University of South Carolina, Charleston, SC, USA.

Center for Biomedical Imaging, Medical University of South Carolina, Charleston, SC, USA.

出版信息

Ann Neurol. 2022 Jun;91(6):864-877. doi: 10.1002/ana.26353. Epub 2022 Mar 30.

Abstract

OBJECTIVE

The Alzheimer's continuum is biologically defined by beta-amyloid deposition, which at the earliest stages is superimposed upon white matter degeneration in aging. However, the extent to which these co-occurring changes is characterized is relatively underexplored. The goal of this study was to use diffusional kurtosis imaging (DKI) and biophysical modeling to detect and describe amyloid-related white matter changes in preclinical Alzheimer disease.

METHODS

Cognitively unimpaired participants ages 45 to 85 years completed brain magnetic resonance imaging, amyloid positron emission tomography (florbetapir), neuropsychological testing, and other clinical measures at baseline in a cohort study. We tested whether beta-amyloid-negative (AB-) and -positive (AB+) participants differed on DKI-based conventional (ie, fractional anisotropy [FA], mean diffusivity [MD], mean kurtosis) and modeling (ie, axonal water fraction [AWF], extra-axonal radial diffusivity [D ]) metrics, and whether these metrics were associated with other biomarkers.

RESULTS

We found significantly greater diffusion restriction (higher FA/AWF, lower MD/D ) in white matter in AB+ than AB- (partial η  =0.08-0.19), more notably in the extra-axonal space within primarily late myelinating tracts. Diffusion metrics predicted amyloid status incrementally over age (area under the curve = 0.84) with modest yet selective associations, where AWF (a marker of axonal density) correlated with speed/executive functions and neurodegeneration, whereas D (a marker of gliosis/myelin repair) correlated with amyloid deposition and white matter hyperintensity volume.

INTERPRETATION

These results support prior evidence of a nonmonotonic change in diffusion behavior, where an early increase in diffusion restriction is hypothesized to reflect inflammation and myelin repair prior to an ensuing decrease in diffusion restriction, indicating glial and neuronal degeneration. ANN NEUROL 2022;91:864-877.

摘要

目的

阿尔茨海默病连续体在生物学上由β-淀粉样蛋白沉积定义,在早期阶段,它与衰老过程中的白质变性叠加在一起。然而,这些共同发生的变化的程度相对来说还没有得到充分的探索。本研究的目的是使用弥散峰度成像(DKI)和生物物理模型来检测和描述临床前阿尔茨海默病中与淀粉样蛋白相关的白质变化。

方法

在一项队列研究中,年龄在 45 岁至 85 岁之间的认知正常的参与者完成了脑磁共振成像、淀粉样蛋白正电子发射断层扫描(florbetapir)、神经心理学测试和其他临床测量。我们测试了β-淀粉样蛋白阴性(AB-)和阳性(AB+)参与者在基于 DKI 的常规(即各向异性分数[FA]、平均扩散系数[MD]、平均峰度)和建模(即轴突水分数[AWF]、细胞外轴突径向扩散系数[D ])指标上是否存在差异,以及这些指标是否与其他生物标志物相关。

结果

我们发现 AB+组的白质弥散受限(更高的 FA/AWF,更低的 MD/D )明显大于 AB-组(部分η=0.08-0.19),尤其是在主要在晚期髓鞘化的轨道内的细胞外空间。扩散指标随着年龄的增长可以递增地预测淀粉样蛋白状态(曲线下面积=0.84),具有适度但选择性的关联,其中 AWF(轴突密度的标志物)与速度/执行功能和神经退行性变相关,而 D(神经胶质增生/髓鞘修复的标志物)与淀粉样蛋白沉积和白质高信号体积相关。

结论

这些结果支持了先前关于扩散行为呈非单调变化的证据,即扩散受限的早期增加被假设为炎症和髓鞘修复的反映,随后是扩散受限的减少,表明神经胶质和神经元变性。ANN NEUROL 2022;91:864-877。

相似文献

引用本文的文献

10
White matter dementia then… and now.白质痴呆:过去与现在
Front Neurol. 2022 Nov 21;13:1043583. doi: 10.3389/fneur.2022.1043583. eCollection 2022.

本文引用的文献

5
Alzheimer's disease drug development pipeline: 2021.2021年阿尔茨海默病药物研发进展
Alzheimers Dement (N Y). 2021 May 25;7(1):e12179. doi: 10.1002/trc2.12179. eCollection 2021.
8
Intracranial Abnormalities with Diffusion Restriction.颅内异常伴弥散受限。
Magn Reson Imaging Clin N Am. 2021 May;29(2):137-161. doi: 10.1016/j.mric.2021.02.004.
10
White matter microstructure disruption in early stage amyloid pathology.早期淀粉样蛋白病变中的白质微结构破坏
Alzheimers Dement (Amst). 2021 Apr 1;13(1):e12124. doi: 10.1002/dad2.12124. eCollection 2021.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验